These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22202383)

  • 1. [Peritoneal lavage cytology under local anesthesia for detection of peritoneal recurrence after surgery].
    Okada K; Fujiwara Y; Takahashi T; Kurokawa Y; Yamasaki M; Miyata H; Nakajima K; Takiguchi S; Mori M; Doki Y
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2363-5. PubMed ID: 22202383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical trials of neo-adjuvant chemotherapy for advanced gastric cancer with peritoneal dissemination].
    Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamazaki M; Nishida T; Doki Y
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):1996-8. PubMed ID: 19106502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neoadjuvant chemotherapy for gastric cancer with peritoneal dissemination].
    Fujiwara Y; Doki Y; Takiguchi S; Miyata H; Yamazaki M; Nishida T; Monden M
    Gan To Kagaku Ryoho; 2007 Nov; 34(12):1923-5. PubMed ID: 18219854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination.
    Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
    J Surg Oncol; 2012 Jan; 105(1):38-42. PubMed ID: 21882194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of advanced gastric cancer with peritoneal dissemination successfully treated with S-1 and intraperitoneal docetaxel administration].
    Narita T; Suzuki A; Hashizume E; Yajima M
    Gan To Kagaku Ryoho; 2012 Jan; 39(1):119-22. PubMed ID: 22241365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test.
    Yamashita K; Ushiku H; Katada N; Hosoda K; Moriya H; Mieno H; Kikuchi S; Hoshi K; Watanabe M
    Eur J Surg Oncol; 2015 Oct; 41(10):1324-32. PubMed ID: 26251341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment for advanced gastric cancer with positive lavage cytology-systemic versus intraperitoneal chemotherapy].
    Iwasaki Y; Ohashi M; Nunobe S; Iwanaga T; Iwagami S; Takahashi K; Yamaguchi T; Matsumoto H; Nakano D
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2009-11. PubMed ID: 19106506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility study of S-1 and intraperitoneal docetaxel combination chemotherapy for gastric cancer with peritoneal dissemination.
    Fujiwara Y; Nishida T; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Yamamoto K; Moon JH; Mori M; Doki Y
    Anticancer Res; 2010 Apr; 30(4):1335-9. PubMed ID: 20530449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
    Ishigami H; Yamaguchi H; Yamashita H; Asakage M; Kitayama J
    Gastric Cancer; 2017 Mar; 20(Suppl 1):128-134. PubMed ID: 28028665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of cytological status of peritoneal lavage fluid during intraperitoneal chemotherapy for gastric cancer with overt peritoneal dissemination.
    Emoto S; Kitayama J; Ishigami H; Yamaguchi H; Watanabe T
    Ann Surg Oncol; 2015 Mar; 22(3):780-6. PubMed ID: 25216603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Postoperative Chemotherapy After Resection that Leaves No Macroscopically Visible Disease of Gastric Cancer with Positive Peritoneal Lavage Cytology (CY1) or Localized Peritoneum Metastasis (P1a): A Multicenter Retrospective Study.
    Yamaguchi T; Takashima A; Nagashima K; Makuuchi R; Aizawa M; Ohashi M; Tashiro K; Yamada T; Kinoshita T; Hata H; Kawachi Y; Kawabata R; Tsuji T; Hihara J; Sakamoto T; Fukagawa T; Katai H; Higuchi K; Boku N
    Ann Surg Oncol; 2020 Jan; 27(1):284-292. PubMed ID: 31535301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of successful treatment of peritoneal dissemination from gastric cancer with S-1/DOC chemotherapy].
    Okada K; Ebisui C; Nushijima Y; Yanagisawa T; Okamura S; Fukuchi N; Murata K; Yokouchi H; Kinuta M
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2361-3. PubMed ID: 25731523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A very elderly case of recurrent gastric cancer with peritoneal dissemination effectively treated by combination chemotherapy of docetaxel (DOC) and S-1].
    Yamamoto T; Shikano T; Hattori K; Kinoshita T; Hachisuka T; Mori T; Shinohara M; Miyauchi M
    Gan To Kagaku Ryoho; 2010 Aug; 37(8):1569-71. PubMed ID: 20716889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent.
    Yonemura Y; Canbay E; Li Y; Coccolini F; Glehen O; Sugarbaker PH; Morris D; Moran B; Gonzaletz-Moreno S; Deraco M; Piso P; Elias D; Batlett D; Ishibashi H; Mizumoto A; Verwaal V; Mahtem H
    Eur J Surg Oncol; 2016 Aug; 42(8):1123-31. PubMed ID: 27160355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The survival and prognosticators of peritoneal cytology-positive gastric cancer patients who received upfront gastrectomy and subsequent S-1 chemotherapy.
    Kano K; Aoyama T; Maezawa Y; Nakajima T; Ikeda K; Yamada T; Sato T; Oshima T; Rino Y; Masuda M; Ogata T; Cho H; Yoshikawa T
    Int J Clin Oncol; 2017 Oct; 22(5):887-896. PubMed ID: 28456896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case report of the combination therapy with S-1 plus CDDP intraperitoneal chemotherapy for CY positive cancer patient].
    Ishii Y; Iwasaki Y; Ohashi M; Iwanaga T; Ohinata R; Takahashi K; Matsumoto H; Yamaguchi T; Nakano D
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2084-6. PubMed ID: 22202291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: Selection for cytoreductive surgery.
    Yonemura Y; Endou Y; Shinbo M; Sasaki T; Hirano M; Mizumoto A; Matsuda T; Takao N; Ichinose M; Mizuno M; Miura M; Ikeda M; Ikeda S; Nakajima G; Yonemura J; Yuuba T; Masuda S; Kimura H; Matsuki N
    J Surg Oncol; 2009 Sep; 100(4):311-6. PubMed ID: 19697437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination.
    Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Okada K; Mori M; Doki Y
    Ann Surg Oncol; 2011 Dec; 18(13):3726-31. PubMed ID: 21584835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of scirrhous gastric cancer with peritoneal dissemination acquiring stable disease over three years by treatment with oral anticancer drug S-1].
    Tanabe D; Kondou K; Uchiyama T; Noda K
    Gan To Kagaku Ryoho; 2008 Aug; 35(8):1391-3. PubMed ID: 18701856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of gastric cancer with intensive peritoneal dissemination treated with long-term chemotherapy and surgery].
    Shirai J; Cho H; Fujikawa H; Iwasaki K; Ogata T; Yoshikawa T; Tsuburaya A; Sujishi K; Yamada T; Osaragi T; Yoneyama K; Kasahara A; Yamamoto Y; Rino Y; Masuda M
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2194-6. PubMed ID: 24394057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.